Towards Healthcare
Carrier Screening Market to Rise at 19.65% CAGR till 2035

Carrier Screening Market Future Demand Driven by IVF Growth

Market insights predict, the carrier screening industry is expected to grow from USD 3.09 billion in 2025 to USD 18.58 billion by 2035, driven by a CAGR of 19.65%.  An immense growth in prenatal screening programs and early detection is mainly influencing the global market expansion. Whereas, the presence of robust healthcare policies and systems is fueling North America’s market development.

Content

  • Last Updated: 17 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The carrier screening market is valued at USD 3.70 billion in 2026 and is on track to reach USD 18.58 billion by 2035, witnessing a steady CAGR of 19.65% during the forecast span.

North America is currently leading the carrier screening market share 42% due to its robust healthcare policies and infrastructure.

The carrier screening market includes six segments such as by test type, by technology, by indication, by end use, by patient group, and by region.

Some key players include Illumina Inc., Thermo Fisher Scientific Inc., Natera Inc., Myriad Genetics Inc., and Invitae Corporation.

Carrier screening can be done in preconception, during pregnancy, and before IVF.

Screening tests are important in IVF as they offer fertility assessment, monitoring egg maturation, and improving success rates.

NHGRI, NIH, US FDA, CGE, ClinicalTrials.gov, WA.GOV, CDC, PIB, NCI, NSW, etc.
Any Questions